Fix The Patent Laws

DTI reneges on IP policy commitments

On 24 April 2013, Minister of Trade and Industry Rob Davies stated that South Africa’s new intellectual property (IP) policy would not be released for public comment any time soon. This starkly contrasts with a number of promises in the past two years, by both the Minister and officials in the Department of Trade and […]

Ending the book famine for the blind

By Marcus Low This article was originally published on GroundUp on April 10 2013. The original article can be accessed here A treaty that has the potential to change the lives of millions of blind people is at risk of being hijacked by publishers who show no sympathy for the difficulties faced by blind people […]

TAC tweets photo messages to @EU_Commission in protest of the EU’s efforts to block access to affordable medicine

TAC joins global actions against the European Union’s on-going efforts to restrict access to affordable medicines. The EU and India are in the final stages of negotiations for an EU-India free trade agreement (FTA). EU is also currently negotiating FTAs with Egypt, Morocco, Tunisia, Thailand, Vietnam and Malaysia.  The EU has repeatedly attempted to use these […]

Debunking Pharma’s Cant Against the Novartis Judgment: Myth and Fact

Professor Brook K. Baker, Senior Policy Analyst Health GAP April 2, 2013 Novartis, its fellow Big Pharma multinationals, Chambers of Commerce, and PhRMA have all roundly denounced India’s Supreme Court’s decision invalidating Novartis’ patent application for Glivec (Gleevec in the United States) and its affirmation of strict anti-evergreening standards of patentability and inventive step in […]

The 2012/2013 South African Health Review provides an analysis of the draft IP policy

The 2012/2013 South African Health Review was launched on 2 April 2013. The first chapter of the publication reviews ‘Health policy and legislation’ in the country. The chapter includes a useful analysis of the draft intellectual property policy for South Africa, as well as the ruling in the recent docetaxel case. The chapter, which has […]

India’s Supreme Court upholds the right to medicine

For the past 7 years, the Indian government has faced on-going court challenges and bullying by the pharmaceutical company Novartis. Novartis’s challenge has centred on provisions in the Indian Patents Act that exclude new uses and formulations of existing medicines from patentability. Specifically, Novartis challenged India’s rejection of its patent application for the cancer medicine […]

  • About the Campaign

    fix the patent laws
    Fix the Patent Laws is a campaign of the Treatment Action Campaign (TAC). TAC is a non-profit organisation that seeks to ensure that every person living with HIV has access to quality, comprehensive prevention and treatment services to live a healthy life. Through this blog we will highlight how amending South Africa’s Patents Act 57 of 1978 will reduce the cost of medicines, improving the health and saving the lives of millions of South Africans.

  • Read the TAC and MSF campaign pamphlet

  • Latest tweets